MEIP Stock Gains Momentum on Early-Stage Trial Data
When a pharmaceutical company provides a positive update with regards to any of its products, then the stock almost always rises, and that is what has happened with MEIP stock. Positive Development MEI Pharma Inc ... [Read]
GPRO Stock Down 21% After Slashing Guidance Following Production Delays
On Thursday, GPRO stock plunged 19% after GoPro Inc. (NASDAQ:GPRO) reduced its revenue and profit estimate for the latter half of 2019 because of production delays of its new Hero8 Black cameras. GoPro to Commence ... [Read]
NIO Stock Plunges 60% in 2 Weeks: Analysts are Still Skeptical
Chinese electric carmaker NIO Inc (NYSE:NIO) is struggling after the company reported a wider-than-expected loss in Q2 as well as several layoffs in late September. NIO stock has lost 60% since September 20. Disappointing Q2 ... [Read]
GPRO Stock Jumps 30% in a Week: Is it a Reversal?
GPRO stock has been gaining momentum over the past week, with a gain of about 30% and up 50% over the course of September. The stock gained even though there was no specific news from ... [Read]
TROV Stock Soars 22% on Positive Mid-Stage Data at ESMO
TROV stock is one of the biggest biotech stock gainers this morning after TrovaGene Inc (NASDAQ:TROV) reported positive results from its Phase 1b/2 study of onvansertib. Key Details Companies in the therapeutics space strive for ... [Read]
PRGS Stock Plunges 12% After Lower-Than-Excepted Q3 Sales
On Friday, PRGS stock slumped 12% after Progress Software Corp (NASDAQ:PRGS) reported lower-than-expected sales in the third quarter. Moreover, the company lowered its revenue estimate for the current quarter to $116–119 million from $122.1 million. ... [Read]
PIR Stock Tumbles 16% on Significant Q2 Loss: What Next?
PIR stock is one of the leading losers on Thursday after Pier 1 Imports Inc (NYSE:PIR) reported that comparable sales fell 12.6% in Q2 and gross margin tumbled as well. Increased Q2 Loss Over the ... [Read]
ACHN Stock Zooms 17% as FDA Grants BTD for Danicopan
ACHN stock is leading in the biotech sector after Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that the FDA has granted Breakthrough Therapy Designation (BTD) for danicopan (ACH-4471). Investors Cheer the News When a pharmaceutical company releases ... [Read]
OVID Stock Soars 40% in 2 Sessions on Preliminary Drug Results
OVID stock is one of the biggest penny stock gainers in the biotech sector this week after Ovid Therapeutics Inc (NASDAQ:OVID) reported preliminary results from a Phase 2 open-label extension study. Positive Momentum Ovid Therapeutics ... [Read]
OSTK Stock Slumps 15% on Revised Retail Sales for 2019
OSTK stock is one of the biggest losers on Monday after Overstock.com Inc (NASDAQ:OSTK) lowered its retail guidance for the full year. Weak Outlook and New CEO When companies make major announcements before the markets ... [Read]